Core Capital Management & Research’s Medtronic MDT Stock Holding History

Core Capital Management & Research’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.8K	Buy	+418	New	+$33.7K	0.02%	132

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Core Capital Management & Research's MDT Position: Q2 2026 in Review

Core Capital Management & Research opened a new position in Medtronic (MDT) in Q2 2026: 418 shares worth $38.8K. The stake represents 0.02% of the portfolio and ranks #132 among its holdings.

2,145 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Core Capital Management & Research held 418 shares of Medtronic worth $38.8K as of Q2 2026.
Medtronic was a new Core Capital Management & Research position in Q2 2026.
Medtronic made up 0.02% of Core Capital Management & Research's portfolio in Q2 2026, its #132 holding.
2,145 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Core Capital Management & Research's 13F filing for Q2 2026, filed 9 Sep 2026.